LMR Partners LLP Makes New $11.04 Million Investment in The Clorox Company (NYSE:CLX)

LMR Partners LLP bought a new stake in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 68,000 shares of the company's stock, valued at approximately $11,044,000. LMR Partners LLP owned approximately 0.05% of Clorox as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in CLX. Vanguard Group Inc. boosted its position in Clorox by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock valued at $2,518,517,000 after buying an additional 124,428 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Clorox by 2.3% in the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock valued at $501,925,000 after acquiring an additional 69,969 shares during the last quarter. Stifel Financial Corp boosted its holdings in shares of Clorox by 0.4% in the 4th quarter. Stifel Financial Corp now owns 2,344,408 shares of the company's stock worth $380,761,000 after acquiring an additional 9,582 shares in the last quarter. Norges Bank bought a new stake in Clorox during the 4th quarter worth approximately $259,041,000. Finally, Northern Trust Corp increased its holdings in Clorox by 18.2% during the 4th quarter. Northern Trust Corp now owns 1,494,265 shares of the company's stock valued at $242,684,000 after purchasing an additional 230,173 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on CLX. Morgan Stanley decreased their target price on Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. DA Davidson decreased their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a report on Wednesday, February 5th. JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating for the company in a research report on Tuesday, May 6th. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Finally, Barclays lowered their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a report on Wednesday, May 7th. Three research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $151.23.

Insider Activity at Clorox

In other news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction on Wednesday, May 7th. The stock was purchased at an average price of $136.57 per share, with a total value of $546,280.00. Following the completion of the purchase, the director now owns 4,000 shares of the company's stock, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.57% of the stock is currently owned by corporate insiders.

Clorox Trading Up 1.2%

CLX stock traded up $1.58 during midday trading on Thursday, reaching $134.99. The company's stock had a trading volume of 1,566,890 shares, compared to its average volume of 1,313,861. The business's 50-day simple moving average is $141.56 and its 200-day simple moving average is $153.64. The stock has a market cap of $16.64 billion, a PE ratio of 36.88, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 316.87% and a net margin of 6.38%. The firm's revenue for the quarter was down 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.71 earnings per share. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd were paid a $1.22 dividend. The ex-dividend date of this dividend was Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.62%. Clorox's dividend payout ratio (DPR) is presently 87.61%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.